Thalidomide

CAS 50-35-1 4 current records 5 historicalSmall Molecule

Who holds supplier records for Thalidomide? 4 organisations hold a current record for Thalidomide: an active US FDA Type II Drug Master File. A further 5 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Thalidomide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/thalidomide

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Thalidomide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Thalidomide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (5)

Organisations whose Type II DMFs for Thalidomide are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • MYLAN LABORATORIES LTD
    Inactive DMF 29452 · filed Jun 2015
  • India · Inactive DMF 22678 · filed Mar 2009
  • Italy · Inactive DMF 21806 · filed Jul 2008
  • SIFAVITOR SRL
    Inactive DMF 15291 · filed Feb 2001
  • ANDRULIS PHARMACEUTICALS CORP
    Inactive DMF 8263 · filed Oct 1989

Overview

Thalidomide is a medication used to treat certain cancers and inflammatory conditions. Despite its notorious history for causing birth defects, it is now used under strict controls for specific medical purposes.

Chemical identity

IUPAC name
2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
Canonical SMILES
C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
InChIKey
UEJJHQNACJXSKW-UHFFFAOYSA-N
Synonyms
Thalomid API, .alpha.-(n-phthalimido)glutarimide, .alpha.-phthalimidoglutarimide, celgene, contergan, distaval, k-17, kevadon, myrin, n-phthalylglutamic acid imide, neurosedyn, nsc-527179

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Physiologic effect
Decreased Immunologically Active Molecule Activity

Therapeutic areas

OncologyImmunology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Thalidomide?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Thalidomide: Hetero Labs Limited (India), Laurus Labs Limited (India), OLON SPA (Italy) and SHILPA PHARMA LIFESCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Thalidomide Drug Master Files are active?

Hetero Labs Limited (DMF 19745), Laurus Labs Limited (DMF 27967), OLON SPA (DMF 18448) and SHILPA PHARMA LIFESCIENCES LTD (DMF 33088). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Thalidomide records mean?

5 organisations have only inactive Type II DMFs for Thalidomide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Thalidomide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Thalidomide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.